3 results match your criteria: "Scientific and Clinical Antituberculosis Center of Moscow Government Health Department[Affiliation]"
PLoS One
May 2019
Clinical Research, Scientific and Clinical Antituberculosis Center of Moscow Government Department of Clinical Research, Scientific and Clinical Antituberculosis Center of Moscow Government Health Department, Moscow, Russian Federation.
Background: A group of Russian scientists has developed Diaskintest, which comprises Mycobacterium tuberculosis-specific recombinant proteins CFP10-ESAT6, for skin testing (0.2 μg/0.1 ml).
View Article and Find Full Text PDFPLoS One
February 2019
Department of problems of laboratory diagnostics of tuberculosis and pathomorphology, Scientific and Clinical Antituberculosis Center of Moscow Government Health Department, Moscow, Russian Federation.
Objective: The objective of the research was to assess the susceptibility of the slowly growing nontuberculous mycobacteria strains to the antimicrobial drugs used for mycobaterioses treatment using SLOMYCO test system.
Materials And Methods: We assessed 363 NTM strains: 177 MAC (161 M. avium, 16 M.
J Antimicrob Chemother
October 2013
Moscow Scientific and Clinical Antituberculosis Center of Moscow Government Health Department, Moscow, 107014 Stromynka 10, Russia.
Objectives: To determine critical concentrations of moxifloxacin and gatifloxacin for rapid evaluation of drug susceptibility of Mycobacterium tuberculosis in Middlebrook 7H9 broth using the automated system BACTEC™ MGIT™ 960.
Methods: In total we studied 152 strains. Critical concentrations of moxifloxacin and gatifloxacin in the BACTEC™ MGIT™ 960 and on Lowenstein-Jensen medium were determined using a panel of 68 strains.